| abstract |
Described are compounds of formula (Ia) which can be used to improve mRNA splicing in a cell. The illustrative compounds described herein can be used to improve mRNA splicing in genes containing at least one exon terminating in a CAA nucleotide sequence. In addition, methods for preparing said compounds and methods for treating diseases of the central nervous system are described, as well as pharmaceutical compositions containing said compounds. |